➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Baxter
Merck
Johnson and Johnson
Moodys

Last Updated: January 28, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for AZD5718

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for AZD5718?

AZD5718 is an investigational drug.

There have been 11 clinical trials for AZD5718. The most recent clinical trial was a Phase 1 trial, which was initiated on October 5th 2020.

The most common disease conditions in clinical trials are Coronary Artery Disease, Myocardial Ischemia, and Coronary Disease. The leading clinical trial sponsors are AstraZeneca, Parexel, and National University Heart Centre, Singapore.

There is one US patent protecting this investigational drug and thirty-five international patents.

Recent Clinical Trials for AZD5718
TitleSponsorPhase
PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromEAstraZenecaPhase 2
PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromENational University Heart Centre, SingaporePhase 2
A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney DiseaseGeorge Clinical Pty LtdPhase 2

See all AZD5718 clinical trials

Clinical Trial Summary for AZD5718

Top disease conditions for AZD5718
Top clinical trial sponsors for AZD5718

See all AZD5718 clinical trials

International Patents for AZD5718

Drugname Country Document Number Estimated Expiration Related US Patent
AZD5718 Argentina AR104512 2035-05-04   Start Trial
AZD5718 Australia AU2016258874 2035-05-04   Start Trial
AZD5718 Brazil BR112017022757 2035-05-04   Start Trial
AZD5718 Canada CA2983668 2035-05-04   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Baxter
Merck
Johnson and Johnson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.